Jan 9, 2017Indigo’s Preliminary Commercial Data Demonstrate Significant Yield Gains for Growers with Plant MicrIndigo™ Cotton demonstrated an average yield improvement of 11% in the target environment of West Texas Farmers experienced productivity...
Jan 6, 2017Vir Biotechnology Launches To Cure, Treat, And Prevent Challenging Infectious Diseases Using Latest -Former Biogen leader George Scangos will be CEO, with Vicki Sato as Chairman of the Board -Company to apply immune programming at...
Dec 6, 2016Sienna Biopharmaceuticals Acquires Creabilis plcAcquisition Adds Phase IIb Product, Clinical Candidates and Novel Discovery Platform to Sienna's Growing Pipeline WESTLAKE VILLAGE,...
Oct 20, 2016BlackThorn Therapeutics Launches to Develop Novel, Targeted Treatments for Neurobehavioral DisordersSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--BlackThorn Therapeutics, a clinical stage biopharmaceutical company discovering and...
Jul 21, 2016Indigo Raises $100M in Series C Funding; Company Launches First Commercial Product for Water EfficieBOSTON, MASS. — July 21, 2016 — Indigo, a company dedicated to harnessing nature to help farmers sustainably feed the planet, announced...
Jul 12, 2016Sienna Biopharmaceuticals Announces Second Closing of Series A FinancingSTRONG INVESTOR DEMAND INCREASES TOTAL INVESTMENTS TO $46M Westlake Village, CA, July 12, 2016 – Sienna Biopharmaceuticals, Inc....
Jan 5, 2016Millendo Therapeutics snags $62 Million Series BAnn Arbor, Michigan-based Millendo Therapeutics (formerly known as Atterocor Inc), a biopharmaceutical company focused on treating orphan...
Dec 23, 2015eFFECTOR Therapeutics Raises $40 Million Series B FinancingSAN DIEGO, December 22, 2015 – eFFECTOR Therapeutics, a biopharmaceutical company developing translation regulators for the treatment of...